COMMUNIQUÉS West-GlobeNewswire

Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
23/07/2025
Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance pipeline expansion [...]
Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025
23/07/2025
WESTLAKE VILLAGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
LightLife Health Solution Launches Mediterranean-Inspired Wellbeing Programs in South Africa and the USA.
23/07/2025
Chef & Sommelier–Turned-Health Coach Reveals Mediterranean Method That Helps Clients Lose Weight and Sleep Better Naturally. CAPE TOWN, Western Cape, July 23, 2025 (GLOBE NEWSWIRE) -- LightLife Health Solution , a [...]
Invitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti Gupta
23/07/2025
Idorsia will publish its Half Year 2025 Financial Reporting on Wednesday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: Wednesday, July 30, [...]
Healthcare Heroes PLLC is launching a nationwide wellness certification initiative.
23/07/2025
Healthcare Heroes PLLC Launches National Wellness Certification to Transform U.S. Healthcare Culture FRISCO, TX, July 23, 2025 (GLOBE NEWSWIRE) -- Healthcare Heroes PLLC , a wellness-focused organization based in Texas [...]
Valley Hemp Introduces THCa Flower Wholesale Guide for 2025 Hemp Market Growth
23/07/2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- With consumers increasingly turning to natural wellness products, THCa flower has become one of the most discussed hemp options on the market. In response to this growing [...]
Muscle Building Supplements 2025: CrazyBulk Introduces Effective Bodybuilding Supplements For Muscle Growth, Bulking, Cutting And Strength in USA
23/07/2025
Muscle Building Supplements: A Game-Changer in Strength Training Programs New York City, NY, July 23, 2025 (GLOBE NEWSWIRE) -- When it comes to enhancing muscle mass, strength, and performance, supplements have become [...]
SAFE - Signature d’un avenant n°5 au contrat de financement obligataire en vigueur afin de poursuivre le retournement stratégique de Safe
23/07/2025
Avertissement : La société SAFE SA (la « Société ») a mis en place un financement sous forme d’obligations convertibles en actions nouvelles ou existantes (OCEANE) avec Global Corporate Finance Opportunities 20 (« GCFO [...]
AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches
23/07/2025
BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces service and infrastructure enhancements [...]
PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio
23/07/2025
New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high- [...]
Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock
23/07/2025
Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock Published in Intensive Care Medicine, Inotrem’s results highlight the pivotal role of the soluble TREM-1 [...]
Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology
23/07/2025
July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health [...]
Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore Immune Function in the Elderly
23/07/2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed [...]
Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company
23/07/2025
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph.D. as Chief [...]
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
23/07/2025
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Akari Therapeutics Continues Key Research on its Novel Antibody Drug Conjugate Payload PH1 to Further Demonstrate its Unique Ability to Target Cancers Fueled by Oncogenic Drivers
23/07/2025
PH1 modulates RNA splicing, causing cancer cell death while activating the immune system to attack cancer throughout the body Company advancing pipeline of ADCs using PH1 payload across both Trop2 and an undisclosed [...]
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer
23/07/2025
Proven drug development leader to drive company’s pipeline of highly CNS-penetrant and precision-designed peripherally restricted small molecules toward clinical milestones SOUTH SAN FRANCISCO, Calif., July 23, 2025 ( [...]
Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody
23/07/2025
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026 WIN378 has the potential to be the first-to-market long-acting, anti [...]
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 43rd Annual Meeting July 29-August 2
23/07/2025
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from [...]

Pages